capital increase, VAVA agrees not to sell the newly issued ordinary shares (Silent Period) which receives from subscription for a period of 1 year from the trading date on the SET. Upon the expiry of the 6
issued ordinary shares (Silent Period) which receives from subscription for a period of 1 year from the trading date on the SET. Upon the expiry of the 6-month period of the prescribed time, VAVA can sell
สารสนเทศข่าว มติ BOD 5-60 Final 20171126 En No. NDR013/2017 Subject Resolution of the Board of Directors’ Meeting To President The Stock Exchange of Thailand Enclosure 1. Information Memorandum on 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form (F53 N.D. Rubber Public Company Limited (“ No.5/2017 held on November26, 2017 which has the material resolutions as follows 1. Approved to propo...
PRI signatories in 2021 New high record of USD 121 trillion collective AUM The rise of sustainable investing & the growing shift to intangible. Thailand perspective: Source: PRI report, Morning Star
ordinary shares or equals to 100% of paid-up capital 10 Nature of Business: FKRMM started its business as motorcycle tire and tube manufacturer using high technology from Japan. In 2004, FKRMM decided to
started its business as motorcycle tire and tube manufacturer using high technology from Japan. In 2004, FKRMM decided to cease its business due to shortage of labor. As a result, FKRMM changed from
Business: FKRMM started its business as motorcycle tire and tube manufacturer using high technology from Japan. In 2004, FKRMM decided to cease its business due to shortage of labor. As a result, FKRMM
tire and tube manufacturer using high technology from Japan. In 2004, FKRMM decided to cease its business due to shortage of labor. As a result, FKRMM changed from motorcycle tire and tube manufacturer
) Fundamental Knowledge (2) Related Rules and Appropriate Investment Advisory (3) Knowledge on non-complex capital market products and high-risk or complex products, i.e., derivatives, high-risk or complex of